WALLBOX NV (WBX)

NL0015000M91 - Common Stock

0.5296  +0.05 (+11.03%)

After market: 0.5368 +0.01 (+1.36%)

Fundamental Rating

2

WBX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 88 industry peers in the Electrical Equipment industry. WBX may be in some trouble as it scores bad on both profitability and health. WBX is valued quite expensive, but it does show an excellent growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

WBX had negative earnings in the past year.
WBX had a negative operating cash flow in the past year.
WBX had negative earnings in each of the past 5 years.
WBX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

WBX's Return On Assets of -23.22% is in line compared to the rest of the industry. WBX outperforms 43.18% of its industry peers.
WBX has a worse Return On Equity (-102.14%) than 64.77% of its industry peers.
Industry RankSector Rank
ROA -23.22%
ROE -102.14%
ROIC N/A
ROA(3y)-34.46%
ROA(5y)-27.22%
ROE(3y)-94.21%
ROE(5y)-88.2%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 36.82%, WBX belongs to the top of the industry, outperforming 84.09% of the companies in the same industry.
In the last couple of years the Gross Margin of WBX has declined.
WBX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.09%
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

WBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
WBX has more shares outstanding than it did 1 year ago.
WBX has a worse debt/assets ratio than last year.

2.2 Solvency

WBX has an Altman-Z score of -1.46. This is a bad value and indicates that WBX is not financially healthy and even has some risk of bankruptcy.
WBX has a worse Altman-Z score (-1.46) than 69.32% of its industry peers.
A Debt/Equity ratio of 1.27 is on the high side and indicates that WBX has dependencies on debt financing.
WBX has a worse Debt to Equity ratio (1.27) than 76.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z -1.46
ROIC/WACCN/A
WACC9.51%

2.3 Liquidity

A Current Ratio of 1.16 indicates that WBX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, WBX is doing worse than 79.55% of the companies in the same industry.
WBX has a Quick Ratio of 1.16. This is a bad value and indicates that WBX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, WBX is doing worse than 80.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.68

More info and screens

7

3. Growth

3.1 Past

WBX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.46%, which is quite impressive.
The Revenue has grown by 16.10% in the past year. This is quite good.
Measured over the past years, WBX shows a very strong growth in Revenue. The Revenue has been growing by 93.97% on average per year.
EPS 1Y (TTM)29.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.11%
Revenue 1Y (TTM)16.1%
Revenue growth 3Y93.97%
Revenue growth 5YN/A
Sales Q2Q%47.88%

3.2 Future

WBX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.15% yearly.
Based on estimates for the next years, WBX will show a very strong growth in Revenue. The Revenue will grow by 48.63% on average per year.
EPS Next Y16.73%
EPS Next 2Y26.31%
EPS Next 3Y21.12%
EPS Next 5Y22.15%
Revenue Next Year9.33%
Revenue Next 2Y12.99%
Revenue Next 3Y32.5%
Revenue Next 5Y48.63%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

WBX's earnings are expected to grow with 21.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.31%
EPS Next 3Y21.12%

More info and screens

0

5. Dividend

5.1 Amount

WBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALLBOX NV

NYSE:WBX (12/20/2024, 8:04:00 PM)

After market: 0.5368 +0.01 (+1.36%)

0.5296

+0.05 (+11.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners10.4%
Inst Owner Change2.06%
Ins Owners3.93%
Ins Owner ChangeN/A
Market Cap133.90M
Analysts80
Price Target2.02 (281.42%)
Short Float %2.41%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.21%
Min Revenue beat(2)-20.52%
Max Revenue beat(2)-5.9%
Revenue beat(4)0
Avg Revenue beat(4)-18.24%
Min Revenue beat(4)-34.56%
Max Revenue beat(4)-5.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.41%
PT rev (3m)-27%
EPS NQ rev (1m)-26.6%
EPS NQ rev (3m)-286.39%
EPS NY rev (1m)-6.66%
EPS NY rev (3m)-80.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.05%
Revenue NY rev (1m)-4.21%
Revenue NY rev (3m)-15.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.69
BVpS0.4
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.22%
ROE -102.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.82%
FCFM N/A
ROA(3y)-34.46%
ROA(5y)-27.22%
ROE(3y)-94.21%
ROE(5y)-88.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.09%
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 109.05%
Cap/Sales 22.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.68
Altman-Z -1.46
F-Score3
WACC9.51%
ROIC/WACCN/A
Cap/Depr(3y)286.33%
Cap/Depr(5y)516.53%
Cap/Sales(3y)39.49%
Cap/Sales(5y)60.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.11%
EPS Next Y16.73%
EPS Next 2Y26.31%
EPS Next 3Y21.12%
EPS Next 5Y22.15%
Revenue 1Y (TTM)16.1%
Revenue growth 3Y93.97%
Revenue growth 5YN/A
Sales Q2Q%47.88%
Revenue Next Year9.33%
Revenue Next 2Y12.99%
Revenue Next 3Y32.5%
Revenue Next 5Y48.63%
EBIT growth 1Y39.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.67%
EBIT Next 3Y24.51%
EBIT Next 5Y26.99%
FCF growth 1Y46.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.97%
OCF growth 3YN/A
OCF growth 5YN/A